Superficial thrombophlebitis

Global Deep Vein Thrombosis (DVT) Pipeline Guide: H1 2020 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 21, 2020
Health, Cardiology, Hematology, Medical specialties, Angiology, Medicine, Venous thrombosis, Thrombosis, Deep vein thrombosis, Deep vein, Superficial thrombophlebitis, Wells score

The "Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This Pharmaceutical and Healthcare pipeline guide, Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020 provides comprehensive information on the therapeutics under development for Deep Vein Thrombosis (DVT) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
  • The Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Deep Vein Thrombosis (DVT) and features dormant and discontinued projects.
  • Formulate corrective measures for pipeline projects by understanding Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline depth and focus of Indication therapeutics.

Insights into the Global Deep Vein Thrombosis (DVT) Market (2018 to 2026) - Opportunity Analysis for New Entrants - ResearchAndMarkets.com

Retrieved on: 
Monday, March 23, 2020
Medical devices, Health, Medical specialties, Angiology, Hematology, Medicine, Deep vein thrombosis, Thrombosis, Venous thrombosis, Deep vein, Superficial thrombophlebitis, Venous stasis

The "Global Deep Vein Thrombosis (DVT) Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Deep Vein Thrombosis (DVT) Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
  • The Global Deep Vein Thrombosis (DVT) Market is poised to grow at a CAGR of around 10.5% over the next decade during 2018 to 2026.
  • Deep vein thrombosis (DVT) is the blood clot that develops in the deep veins of the body.
  • Moreover, advancements in the field of healthcare and increasing government initiatives are the opportunities for the deep vein thrombosis (DVT) market.

Venous Thromboembolism Treatment Market is Expected to Observe a CAGR of 4.0% Over 2019 to 2029 - Future Market Insights

Retrieved on: 
Wednesday, May 15, 2019
Hematology, Medical specialties, Medicine, Venous thrombosis, Thrombosis, Deep vein thrombosis, Embolism, Superficial thrombophlebitis, Low molecular weight heparin

As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 4% CAGR between 2019 and 2029.

Key Points: 
  • As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 4% CAGR between 2019 and 2029.
  • Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market .
  • The first and the most important factor driving the venous thromboembolism treatment market is the increasing prevalence of venous thromboembolism disease.
  • Apart from the driving factors of venous thromboembolism treatment market, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market.

Venous Thromboembolism Treatment Market is Expected to Observe a CAGR of 4.0% Over 2019 to 2029 - Future Market Insights

Retrieved on: 
Wednesday, May 15, 2019
Hematology, Medical specialties, Medicine, Venous thrombosis, Thrombosis, Deep vein thrombosis, Embolism, Superficial thrombophlebitis, Low molecular weight heparin

As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 4% CAGR between 2019 and 2029.

Key Points: 
  • As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 4% CAGR between 2019 and 2029.
  • Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market .
  • The first and the most important factor driving the venous thromboembolism treatment market is the increasing prevalence of venous thromboembolism disease.
  • Apart from the driving factors of venous thromboembolism treatment market, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market.

Deep Vein Thrombosis (DVT) - Pipeline Insight, 2019 by Developmental Stage, Associated Indications, Route of Administration and Molecule Type - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 28, 2019
Health, Pharmaceutical, Hematology, Medical specialties, Medicine, Deep vein thrombosis, Thrombosis, Venous thrombosis, Drug pipeline, Wells score, Superficial thrombophlebitis

The "Deep Vein Thrombosis (DVT) - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Deep Vein Thrombosis (DVT) - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Deep Vein Thrombosis (DVT) development.
  • The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
  • clinical, pre-clinical and discovery stages for Deep Vein Thrombosis (DVT)
    The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
    Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Deep Vein Thrombosis (DVT)
    Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine